Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?

Clin Mol Hepatol > Accepted Articles

Editorial

Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?

Margaret LP Teng¹, Darren Jun Hao Tan², Cheng Han Ng², Daniel Q. Huang^1,2

¹Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore
²Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Correspondence :

Daniel Q. Huang ,
Tel: +65 6772 4354, Fax: +65 6775 1518, Email: daniel_huang@nus.edu.sg

Received: February 23, 2023 Revised: March 13, 2023 Accepted: March 13, 2023

TOOLS

METRICS

0 Crossref
0 Scopus
95 View
4 Download

ORCID iDs

Daniel Q. Huang
https://orcid.org/0000-0002-5165-5061

Related articles

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease

Implications of comorbidities in nonalcoholic fatty liver disease

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

The growing burden of non-alcoholic fatty liver disease on mortality

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

Copyright © The Korean Association for the Study of the Liver.

COUNTER

TODAY : 367

TOTAL : 1211532